Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

K Y Lin, Frank Guarnieri, Kevin F. Staveley-O’Carroll et al. · PubMed · 1996 · 1K citations

Medicine, Immunology, Oncology +17

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality <i>in vivo</i> imaging

Derek W. Bartlett, Helen C. Su, Isabel J. Hildebrandt et al. · Proceedings of the National Academy of Sciences · 2007 · 797 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

In vivo imaging of siRNA delivery and silencing in tumors

Zdravka Medarova, Wellington Pham, Christian T. Farrar et al. · Nature Medicine · 2007 · 693 citations

Pharmacy, Molecular Pharmaceutics, Oncology +14

Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice

Dag R. Sørensen, Marianne Leirdal, Mouldy Sioud · Journal of Molecular Biology · 2003 · 463 citations

Pharmacy, Molecular Biology, Molecular Genetics +17

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

Ming Jiang, Jo Milner · Oncogene · 2002 · 372 citations

Life Sciences, Molecular Biology, Oncology +17